ACS Omega · 2018 · 41 citations · 23 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryMolecular ImagingStructure-activity RelationshipsAmyloid FormationLead Compound DesignLigand BindingNatural Product Drug DiscoveryNeurodegenerative Disease PharmacologyStructure-activity Relationship AnalysisAlpha-synuclein AggregationAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid FibrilsFive-membered HeterocyclesLead Compound DiscoveryPyrazole ChemistryStructure - Activity Relationship Optimization
is a secondary lead compound for structure-activity relationship studies aimed at identifying a suitable compound for positron emission tomography-imaging studies of insoluble Asyn aggregates in Parkinson's disease.
23
VMD: Visual molecular dynamics
William Humphrey, Andrew Dalke, Klaus Schulten · Journal of Molecular Graphics · 1996 · 66.6K citations
What features improve the accuracy of clinical diagnosis in Parkinson's disease
Andrew Hughes, Yoav Ben‐Shlomo, Susan E. Daniel et al. · Neurology · 1992 · 1.3K citations